# A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy

> **NCT01568385** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 30 (actual)

## Conditions studied

- Gastric Ulcer
- Duodenal Ulcer

## Interventions

- **DRUG:** TAK-438

## Key facts

- **NCT ID:** NCT01568385
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01568385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01568385, "A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01568385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*